Red Light Therapy for Multiple sclerosis (MS)
PBM was associated with increased interleukin-10 but no change in nitrite levels in patients with relapsing-remitting MS. The study had no negative control group (Silva 2020)
Evidence Summary
1 human non-RCT
Related Conditions in Neurology
Research Basis
This content is informed by 47+ published peer-reviewed studies on photobiomodulation.
RedLightOS Research Team
Photobiomodulation Research
The RedLightOS team reviews over 9,500 published photobiomodulation studies to deliver evidence-based red light therapy guidance.
Reviewed by RedLightOS Research Team. Last reviewed: . Based on published photobiomodulation research. For educational purposes only — not a substitute for professional medical advice. See our methodology.
Medical Disclaimer: This content is for informational and educational purposes only. It is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Red light therapy devices are wellness devices and are not intended to diagnose, treat, cure, or prevent any disease. Individual results may vary.